ESR1 and breast cancer: Bates et al15 demonstrated that in BC samples, high rate of Treg infiltration was more frequent in patients with ER‐negative, high‐grade tumors, and positive lymph nodes and that it was associated with poor outcomes, even in ER‐positive tumors.